Flaherty Keith T.
Insider CIK 1579310 · CLVS Director · LOXO Director · CMPI Director · KNTE Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KNTE Kinnate Biopharma Inc. | D To issuer deriv | 2024-04-03 | 2024-04-05 | 11,391 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer deriv | 2024-04-03 | 2024-04-05 | 56,112 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer deriv | 2024-04-03 | 2024-04-05 | 20,250 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer deriv | 2024-04-03 | 2024-04-05 | 20,250 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer deriv | 2024-04-03 | 2024-04-05 | 32,064 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer deriv | 2024-04-03 | 2024-04-05 | 25,000 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 66,377 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award deriv | 2023-06-12 | 2023-06-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award deriv | 2022-06-13 | 2022-06-15 | 20,250 | — | $0 | 20,250 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | D To issuer deriv | 2022-05-31 | 2022-05-31 | 10,030 | — | $0 | 0 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | D To issuer deriv | 2022-05-31 | 2022-05-31 | 22,736 | — | $0 | 0 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | D To issuer deriv | 2022-05-31 | 2022-05-31 | 4,012 | — | $0 | 0 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | A Award deriv | 2021-06-16 | 2021-06-21 | 10,030 | — | $0 | 10,030 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award deriv | 2021-06-11 | 2021-06-14 | 20,250 | — | $0 | 20,250 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2021-06-10 | 2021-06-11 | 42,223 | — | $0 | 42,223 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2020-06-04 | 2020-06-05 | 40,138 | — | $0 | 40,138 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2019-06-06 | 2019-06-07 | 28,882 | — | $0 | 28,882 | SEC↗ |
| LOXO Loxo Oncology, Inc. | D To issuer deriv | 2019-02-15 | 2019-02-15 | 11,000 | $235.00 | $2.58M | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | D To issuer deriv | 2019-02-15 | 2019-02-15 | 2,500 | $235.00 | $587.5K | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | D To issuer deriv | 2019-02-15 | 2019-02-15 | 8,750 | $235.00 | $2.06M | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | D To issuer deriv | 2019-02-15 | 2019-02-15 | 32,345 | $235.00 | $7.60M | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | D To issuer deriv | 2019-02-15 | 2019-02-15 | 68,620 | $235.00 | $16.13M | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | D To issuer deriv | 2019-02-15 | 2019-02-15 | 31,459 | $235.00 | $7.39M | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | D To issuer deriv | 2019-02-15 | 2019-02-15 | 15,625 | $235.00 | $3.67M | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | D To issuer deriv | 2019-02-15 | 2019-02-15 | 12,500 | $235.00 | $2.94M | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | D To issuer deriv | 2019-02-15 | 2019-02-15 | 7,812 | $235.00 | $1.84M | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | D To issuer deriv | 2019-02-15 | 2019-02-15 | 7,812 | $235.00 | $1.84M | 0 | SEC↗ |
| LOXO Loxo Oncology, Inc. | D To issuer | 2019-02-15 | 2019-02-15 | 9,732 | $235.00 | $2.29M | 0 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2018-10-11 | 2018-10-15 | 14,770 | — | $0 | 14,770 | SEC↗ |
| LOXO Loxo Oncology, Inc. | A Award deriv | 2018-06-13 | 2018-06-14 | 8,750 | — | $0 | 8,750 | SEC↗ |
| LOXO Loxo Oncology, Inc. | M Exercise deriv | 2018-06-07 | 2018-06-11 | 50,000 | — | $0 | 32,345 | SEC↗ |
| LOXO Loxo Oncology, Inc. | M Exercise | 2018-06-07 | 2018-06-11 | 50,000 | $1.18 | $59.0K | 59,732 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2018-06-07 | 2018-06-11 | 12,243 | $173.32 | $2.12M | 35,934 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2018-06-07 | 2018-06-11 | 4,634 | $172.03 | $797.2K | 48,177 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2018-06-07 | 2018-06-11 | 5,422 | $175.97 | $954.1K | 9,732 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2018-06-07 | 2018-06-11 | 5,021 | $171.15 | $859.3K | 52,811 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2018-06-07 | 2018-06-11 | 1,900 | $169.85 | $322.7K | 57,832 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2018-06-07 | 2018-06-11 | 4,743 | $175.10 | $830.5K | 15,154 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2018-06-07 | 2018-06-11 | 16,037 | $174.04 | $2.79M | 19,897 | SEC↗ |
| LOXO Loxo Oncology, Inc. | A Award deriv | 2018-01-04 | 2018-01-05 | 2,500 | — | $0 | 2,500 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2017-11-20 | 2017-11-22 | 1,961 | $77.33 | $151.6K | 9,732 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2017-11-20 | 2017-11-22 | 800 | $76.29 | $61.0K | 11,693 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2017-11-20 | 2017-11-22 | 4,489 | $75.35 | $338.2K | 12,493 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2017-08-21 | 2017-08-23 | 3,450 | $72.65 | $250.6K | 16,982 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2017-08-21 | 2017-08-23 | 3,800 | $71.91 | $273.3K | 20,432 | SEC↗ |
| LOXO Loxo Oncology, Inc. | A Award deriv | 2017-06-22 | 2017-06-23 | 11,000 | — | $0 | 11,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2017-06-08 | 2017-06-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2017-05-22 | 2017-05-24 | 4,341 | $44.64 | $193.8K | 27,141 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2017-05-22 | 2017-05-24 | 110 | $46.24 | $5.1K | 24,232 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2017-05-22 | 2017-05-24 | 2,799 | $45.75 | $128.1K | 24,342 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2017-02-21 | 2017-02-23 | 7,250 | $41.45 | $300.5K | 31,482 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2016-12-19 | 2016-12-21 | 7,250 | $30.23 | $219.2K | 38,732 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2016-09-07 | 2016-09-09 | 14,500 | $30.00 | $435.0K | 45,982 | SEC↗ |
| LOXO Loxo Oncology, Inc. | S Sale | 2016-08-11 | 2016-08-12 | 15,000 | $26.00 | $390.0K | 60,482 | SEC↗ |
| LOXO Loxo Oncology, Inc. | A Award deriv | 2016-06-10 | 2016-06-13 | 7,812 | — | $0 | 7,812 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2016-06-09 | 2016-06-10 | 10,000 | — | $0 | 10,000 | SEC↗ |
| LOXO Loxo Oncology, Inc. | A Award deriv | 2015-07-28 | 2015-07-30 | 7,812 | — | $0 | 7,812 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2015-06-11 | 2015-06-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| LOXO Loxo Oncology, Inc. | A Award deriv | 2014-12-19 | 2014-12-23 | 12,500 | — | $0 | 12,500 | SEC↗ |
| LOXO Loxo Oncology, Inc. | A Award deriv | 2014-07-31 | 2014-08-01 | 15,625 | — | $0 | 15,625 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2014-06-12 | 2014-06-16 | 12,414 | — | $0 | 12,414 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2013-06-13 | 2013-06-14 | 27,587 | — | $0 | 27,587 | SEC↗ |